Executive Council
The Executive Council of the APV is elected every four years during the annual membership meeting. It consists of up to eight members, who serve the constitutional roles of the council and support the work of the focus groups.
The current Executive Council is made up of:
President
Prof. Dr. Sandra Klein
Institut für Pharmazie
Biopharmazie und Pharmazeutische Technologie
Ernst-Moritz-Arndt-Universität Greifswald
Felix-Hausdorff-Strasse 3
D-17489 Greifswald
Email: Sandra.Klein@uni-greifswald.de
Curriculum vitae
Vice-President
Prof. Dr. Jörg Breitkreutz
Institut für Pharmazeutische Technologie
Heinrich-Heine-Universität Düsseldorf Geb. 26.22
Universitätstr. 1
D-40225 Düsseldorf
Email: joerg.breitkreutz@uni-duesseldorf.de
Treasurer
Dr. Karoline Bechtold-Peters
Novartis Pharma AG
4002 Basel
Werk Klybeck
Switzerland
Email: karoline.bechtold-peters@novartis.com
Secretary
Dr. Alena Wieber
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt, Germany
Email: alena.wieber@merckgroup.com
Member of Executive Council
Prof. Dr. Johannes Bartholomäus
TU Braunschweig and Pharmakreativ Pharmaceutical Development Consulting
Burghöhenweg 5
52080 Aachen, Germany
Member of Executive Council
Dr. Kathrin Bartscher
NextPharma
Im Wirrigen 25
D-45731 Waltrop
Email: Kathrin.bartscher@nextpharma.com
Member of Executive Council
Dr. Martin Lück
Grünenthal GmbH
Zieglerstraße 6
52078 Aachen, Germany
Email: martin.lueck@grunenthal.com
Member of Executive Council
Dr. Florian Unger
Bayer AG
Friedrich-Ebert-Str. 217
42117 Wuppertal, Germany
Email: florian.unger@bayer.com